269 related articles for article (PubMed ID: 33302421)
1. Genomic Analysis of Natural Rough
Kornspan D; Lubkovskaia R; Mathur S; Yeheskel A; Salmon-Divon M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302421
[No Abstract] [Full Text] [Related]
2. Transcriptomic analysis of smooth versus rough Brucella melitensis Rev.1 vaccine strains reveals insights into virulence attenuation.
Salmon-Divon M; Kornspan D
Int J Med Microbiol; 2020 Jan; 310(1):151363. PubMed ID: 31699441
[TBL] [Abstract][Full Text] [Related]
3. Genomic analysis of the original Elberg Brucella melitensis Rev.1 vaccine strain reveals insights into virulence attenuation.
Salmon-Divon M; Yeheskel A; Kornspan D
Virulence; 2018; 9(1):1436-1448. PubMed ID: 30139304
[TBL] [Abstract][Full Text] [Related]
4. Identification of Brucella melitensis Rev.1 vaccine-strain genetic markers: Towards understanding the molecular mechanism behind virulence attenuation.
Issa MN; Ashhab Y
Vaccine; 2016 Sep; 34(41):4884-4891. PubMed ID: 27595444
[TBL] [Abstract][Full Text] [Related]
5. Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export.
González D; Grilló MJ; De Miguel MJ; Ali T; Arce-Gorvel V; Delrue RM; Conde-Alvarez R; Muñoz P; López-Goñi I; Iriarte M; Marín CM; Weintraub A; Widmalm G; Zygmunt M; Letesson JJ; Gorvel JP; Blasco JM; Moriyón I
PLoS One; 2008 Jul; 3(7):e2760. PubMed ID: 18648644
[TBL] [Abstract][Full Text] [Related]
6. Antigenic, immunologic and genetic characterization of rough strains B. abortus RB51, B. melitensis B115 and B. melitensis B18.
Adone R; Muscillo M; La Rosa G; Francia M; Tarantino M
PLoS One; 2011; 6(10):e24073. PubMed ID: 22065984
[TBL] [Abstract][Full Text] [Related]
7. Rough brucella strain RM57 is attenuated and confers protection against Brucella melitensis.
Feng Y; Peng X; Jiang H; Peng Y; Zhu L; Ding J
Microb Pathog; 2017 Jun; 107():270-275. PubMed ID: 28390976
[TBL] [Abstract][Full Text] [Related]
8. Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep.
Barrio MB; Grilló MJ; Muñoz PM; Jacques I; González D; de Miguel MJ; Marín CM; Barberán M; Letesson JJ; Gorvel JP; Moriyón I; Blasco JM; Zygmunt MS
Vaccine; 2009 Mar; 27(11):1741-9. PubMed ID: 19186196
[TBL] [Abstract][Full Text] [Related]
9. Vaccine Candidate Brucella melitensis 16M
Hensel ME; Garcia-Gonzalez DG; Chaki SP; Hartwig A; Gordy PW; Bowen R; Ficht TA; Arenas-Gamboa AM
mSphere; 2020 May; 5(3):. PubMed ID: 32404509
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
[TBL] [Abstract][Full Text] [Related]
11. A Brucella melitensis H38ΔwbkF rough mutant protects against Brucella ovis in rams.
Muñoz PM; Conde-Álvarez R; Andrés-Barranco S; de Miguel MJ; Zúñiga-Ripa A; Aragón-Aranda B; Salvador-Bescós M; Martínez-Gómez E; Iriarte M; Barberán M; Vizcaíno N; Moriyón I; Blasco JM
Vet Res; 2022 Mar; 53(1):16. PubMed ID: 35236406
[TBL] [Abstract][Full Text] [Related]
12. Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model.
Uslu A; Erganis O
Mol Immunol; 2021 May; 133():44-52. PubMed ID: 33631554
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the GI-2 integrase and the wbkA flanking transposase improves the stability of Brucella melitensis Rev 1 vaccine.
Mancilla M; Grilló MJ; de Miguel MJ; López-Goñi I; San-Román B; Zabalza-Baranguá A; Moriyón I
Vet Res; 2013 Oct; 44(1):105. PubMed ID: 24176078
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
Adone R; Francia M; Ciuchini F
Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
[TBL] [Abstract][Full Text] [Related]
15. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
Zhang J; Guo F; Chen C; Li Z; Zhang H; Wang Y; Zhang K; Du G; Li Y; Wang J; Jian T; Wang Z
Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a Brucella melitensis mutant deficient in O-polysaccharide export system ATP-binding protein as a rough vaccine candidate.
Wang Z; Niu JR; Wang XL; Wu TL; Cheng J; Lu L; Wu QM
Microbes Infect; 2014 Aug; 16(8):633-9. PubMed ID: 25043564
[TBL] [Abstract][Full Text] [Related]
17. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
[TBL] [Abstract][Full Text] [Related]
18.
Verdiguel-Fernández L; Oropeza-Navarro R; Ortiz A; Robles-Pesina MG; Ramírez-Lezama J; Castañeda-Ramírez A; Verdugo-Rodríguez A
J Microbiol Biotechnol; 2020 Apr; 30(4):497-504. PubMed ID: 31986561
[TBL] [Abstract][Full Text] [Related]
19. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic Analysis of the
Salmon-Divon M; Zahavi T; Kornspan D
Front Microbiol; 2019; 10():250. PubMed ID: 30837973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
